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ABSTRACT
Group I metabotropic glutamate receptors (mGluRl and mGluR5) are activated
by glutamate, the major excitatory neurotransmitter in the brain. mGluRl/5 stimulation
causes the release of calcium from intracellular stores thereby activating calciumregulated downstream effector enzymes that produce long-lasting changes in synaptic
activity that are implicated in memory, learning, and neurodegenerative diseases.
Therefore, understanding the precise molecular mechanisms underlying mGluRl/5
desensitization is important in understanding the physiological response caused by these
receptors. Recently, we have discovered a novel Group I mGluR-interacting protein,
spinophilin. Spinophilin is a multifunctional protein that regulates the endocytosis of
some GPCRs through its interaction with the receptors third intracellular loop domain.
We find that spinophilin over-expression decreases agonist-stimulated internalization of
mGluRla, does not affect mGluRla-dependent activation of phospholipase C leading to
inositol phosphate formation, but results in attenuated ERK1/2 phosphorylation. Thus,
this study provides evidence that spinophilin regulates the signalling and internalization
of Group I mGluRs.
Keywords: metabotropic glutamate receptor, G protein-coupled receptor, spinophilin,
internalization, extracellular signal-regulated kinase, signalling
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CHAPTER 1
INTRODUCTION
1.1 G-Protein Coupled Receptors

Currently, 50% of pharmacotherapeutics are targeted towards G-protein coupled
receptors (GPCRs) (Gesty-Palmer and Luttrell, 2011). GPCRs reside on the plasma
membrane, where they play a role in a cell’s ability to sense its local environment via
interaction with different types of stimuli including photons, odorants, tastants, amino
acids, saccharides, fatty acids, complex polypeptides and neurotransmitters (Vilardaga,
2010). GPCRs are seven transmembrane domain proteins that have an amino terminus
that is exposed to the extracellular environment and a carboxyl terminus that is exposed
to the intracellular environment. Extracellular signalling molecules are recognized by
the extracellular domain which binds to these molecules inducing a change in receptor
conformation that allows the initiation of an intracellular signalling cascade. The
signalling cascade occurs as a consequence of the interaction of heterotrimeric guanine
nucleotide binding proteins (G-proteins) with the GPCR carboxyl terminus and
intracellular loops. GPCRs have been classified into three families; family A (e.g.
rhodopsin like receptors), family B (e.g. secretin/glucagon receptors) and family C (e.g.
metabotropic glutamate receptors). Metabotropic glutamate receptors (mGluRs) are
unique from other GPCRs due to variation of sequence and structural homology (Dhami
and Ferguson, 2006; Jacoby et al., 2006; Niswender and Conn, 2010).
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1,2 Metabotropic Glutamate Receptors

Glutamate is the major excitatory neurotransmitter in the brain, it is essential for
many physiological processes, including integrative brain function and neuronal cell
development (Bordi and Ugolini, 1999; Nakanishi, 1994). It has been found to interact
with both ionotropic and metabotropic glutamate receptors (mGluRs). When ionotropic
receptors including: N-methyl-D-aspartate receptors (NMDA), alpha-amino-3-hydroxy5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and kainite type cation channels,
become stimulated by glutamate they produce a fast and short cellular response by
increasing the amount of sodium and calcium ions in the cell (Nakanishi, 1994). When
mGluRs become stimulated by glutamate they also cause an influx of calcium in the cell,
and activate downstream effector enzymes that produce long-lasting changes in cellular
activity (Figure 1.1) (Bordi and Ugolini, 1999; Ferraguti et al., 1999; Nakanishi, 1994;
Niswender and Conn, 2010; Wang, J., et al., 2004; Wang, J., et al., 2007). There are
eight types of mGluRs, which are divided into three subgroups based on sequence
homology and G protein activation. Group I contains two subtypes mGluRl and
mGluR5, Group II contains mGluR2 and mGluR3 and Group III contains mGluR4,
mGluR6, mGluR7, and mGluR8. Upon agonist stimulation, Group I mGluRs couple to
the heterotrimeric Gaq/n protein causing the activation of phospholipase C(3, while
Groups II and III negatively regulate adenylyl cyclase via G(Xi/0 (Bordi and Ugolini,
1999; Conn and Pin, 1997). Group I metabotropic receptors are of primary focus in this
thesis, and will be discussed further in the introduction.
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Figure 1.1: Glutamate Signalling in the Synapse. Glutamate interacts with both
ionotropic receptors and mGluRs. When ionotropic receptors including: NMDA
receptors, AMPA receptors, and kainite type cation channels, become stimulated by
glutamate they produce a fast and short cellular response by increasing the amount of
calcium in the cell. When mGluRs become stimulated by glutamate, the GOq/n protein
activates PLC, resulting in the formation of IP3 and DAG. The release of IP3 activates
the IP3 receptor on the ER, causing the release of Ca2+ from intracellular stores. The
increase in Ca2+ and DAG causes the activation of PKC, allowing PKC to phosphorylate
its respective substrates (Bordi and Ugolini, 1999; Conn and Pin, 1997; Nakanishi,
1994). Abbreviations: AMPA, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid; Ca2+, calcium; DAG, diacylglycérol; ER, endoplasmic reticulum; IP3, inositol
1,4,5-triphosphate; mGluRs, metabotropic glutamate receptors; NMDA, N-methyl-Daspartate receptors; PKC, protein kinase C; PLC, phospholipase C.
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1.2.1 Group I mGluR Structure and Distribution

Group I mGluRs have a large N-terminal domain, seven a-helical
transmembrane domains that are separated by short intra- and extra-cellular loops and a
carboxyl-terminal domain of variable length (Figure 1.2). These receptors interact with
glutamate on the extracellular domain that contains two globular domains with a hinge
region (Acher et al., 2011; Conn and Pin, 1997; Niswender and Conn, 2010). Group I
mGluRs consist of two subtypes of receptors, mGluR 1 (with its splice variants a, b, c
and d) and mGluR5 (with its splice variants a and b). The splice variants express
carboxyl tails of variable length, causing them to interact with different protein
complexes and ultimately function differently (Conn and Pin, 1997; Niswender and
Conn, 2010). For example, mGluR la and mGluR5a have long carboxyl tails that are
shown to interact with protein phosphatase ly, Siah-1 A, Homer and PDZ proteins,
whereas mGluR lb lacks the amino acid motifs required for these protein interactions
(Croci et al., 2003; Kammermeier and Ikeda, 2001; Kammermeier, 2008; Kitano et al.,
2002; Niswender and Conn, 2010; Ronesi and Huber, 2008). Additionally, Group I
mGluRs couple to G proteins primarily via their second intracellular loop domains as
well as their carboxyl tails (Conn and Pin, 1997; Niswender and Conn, 2010).
In the central nervous system (CNS), Group I mGluRs are located in the
hippocampus, cortex, thalamus and cerebellum (Byrnes et al., 2009). mGluR 1 is highly
expressed in the CA3 region and the dentate gyrus of the hippocampus and Purkinje
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Figure 1.2: Schematic of the Secondary Amino Acid Sequence of mGluRla.
Illustrated is the glutamate binding domain, transmembrane topology, and the regions
involved in agonist binding and G protein coupling (Dhami and Ferguson, 2006). The
amino acid residues of the PDZ binding motif are also illustrated. Abbreviations: PDZ,
PSD-95/Discs large/ZO-1 homology; TMD, transmembrane domain.
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cells in the cerebellum, but it is also expressed in lower quantities in the olfactory bulb,
amygdala, thalamus and basal ganglia (Martin et al., 1992; Shigemoto et al., 1992).
Additionally, the splice variants mGluRla and mGluRlb are distributed differently,
mGluRlb is enriched in the cortex and hippocampus, while both mGluRla and
mGluRlb are expressed in the olfactory bulb, thalamus and cerebellum (Ferraguti et al.,
1998). Interestingly, mGluR5 is not as abundant as mGluRl in the cerebellum, although
it is expressed in abundance in CA1 and CA3 pyramidal cells and granule cells in the
olfactory bulb (Bordi and Ugolini, 1999; Romano et al., 1995). Additionally, mGluR5a
is found to be abundant in young developing rat brain, and mGluR5b is predominant in
adult rat brain (Romano et al., 1996). Group I mGluRs are also expressed in the skin,
melanocytes, osteoblasts, heart cells and hepatocytes (Dhami and Ferguson, 2006).
However, this thesis is only focused on the signalling and function of Group I mGluRs
in the CNS. Group I mGluRs are found both in presynatpic and postsynaptic sites in the
brain, although they are primarily located postsynaptically, where they play a large role
in regulating neuronal activity (Bordi and Ugolini, 1999; Martin et al., 1992).

1.2.2 Signalling by Group 1 Metabotropic Glutamate Receptors

The primary signalling cascade mediated by Group I mGluRs is through
coupling to the heterotrimeric Gaq/n proteins, which ultimately causes an increase of
intracellular calcium and stimulation of second messenger dependent proteins that
produce long lasting changes inside the cell (Dhami and Ferguson, 2006; Kawabata et
al., 1998; Wang, J., et al., 2007). After mGluRl/5 agonist stimulation, the receptor
changes its conformation allowing the exchange of GDP to GTP on the heterotri meric
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Gttq/n protein, this causes the disassociation of the Ga*GTPand G(3y proteins, allowing
them to interact with and activate their respective effector enzymes (Ferguson, 2001;
Nakanishi, 1994). The Gaq/n proteins activate phospholipase C(31, which cleaves
phosphatidylinositol 4,5-bisphosphate (PIP2) from the plasma membrane resulting in the
formation of inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). The release of
IP3 activates the IP3 receptor on the endoplasmic reticulum, causing the release of
calcium (Ca+2) from intracellular stores. The increase in Ca+2 and DAG causes the
activation of protein kinase C (PKC), allowing PKC to phosphorylate its respective
substrates. The activation of mGluRl/5 causes an oscillatory production of DAG, IP3,
and Ca+2, which leads to oscillations in PKC activation (Dale et al., 2001; Dale et al.,
2002; Kawabata et al., 1998). Interestingly, the frequency of oscillations differs
between mGluRl and mGluR5, which translate to different PKC oscillations (Dale et al.,
2001; Kawabata et al., 1998). Several agonists have been characterized for Group I
mGluRs, the most potent being quisqualate, followed by 3,5-dihydroxyphenylglycine
glutamate (DHPG) which both primarily activate Gaq/n proteins, but have also been
shown to couple mGluRl/5 with Gas and Gayoproteins, which leads to increased cAMP
formation and the release of arachidonic acid (Aramori and Nakanishi, 1992; Bordi and
Ugolini, 1999; Conn and Pin, 1997; Dale et al., 2002). Coupling to the heterotrimeric
Gaq/n proteins also leads to the activation of effector proteins, such as protein kinase C
(PKC), protein kinase D (PKD), proline-rich tyrosine kinase 2 (Pyk2), proto-oncogene
tyrosine-protein kinase (Src), Ca2+/calmodulin-dependent protein kinases II (CaMKII)
and extracellular signal-regulated kinases (ERK). mGluRl/5 signalling also leads to the
potentiation of voltage-dependent calcium channels and the inhibition of potassium
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conduction (Dale et al., 2001; Dhami and Ferguson, 2006; Krueger et al., 2010; Lu et al.,
1999; Nicodemo et al., 2010; Wang, J., et al., 2004).
I. 2.3 Activation of Mitogen-Activated Protein Kinases

Agonist stimulation of Group I mGluRs also causes the stimulation of p44 and
p42 mitogen-activated protein kinases (MAPK). Two proteins from the MAPK family
have been found to be phosphorylated by mGluRl/5 stimulation, extracellular signalregulated kinase 1 (ERK1) and 2 (ERK2). The activation of these proteins allows them
to transduce the activity of extracellular and intracellular signals into long lasting
changes in the CNS by regulating cellular activities and gene transcription (Wang, J., et
al., 2007). Studies have found that DHPG stimulation increases ERK phosphorylation in
the spinal cord, hippocampus and glia (Gallagher et al., 2004; Karim et al., 2001 ; Peavy
and Conn, 1998). Additionally, mGluR5 signalling causes ERK2 phosphorylation in
astrocytes (Peavy et al., 2001). The activation of MAPK can occur in many ways, some
studies have found that it is primarily through a calcium independent route, our group
has found that Pyk2 is required for ERK 1/2 phosphorylation in cortical neurons, while
others have found that PKC and Homer proteins also contribute to ERK 1/2
phosphorylation (Ferraguti et al., 1999; Mao et al., 2005; Nicodemo et al., 2010; Wang,
J. , et al., 2007).

Additionally, other studies have found that internalization of mGluRl

by p-arrestin causes a direct activation of MAPK, while others have shown that ERK
phosphorylation can occur by the GPy subunits and Src tyrosine kinases (Emery et al.,
2010; Iacovelli et al., 2003; Luttrell et al., 1997; Wang, J., et al., 2007). Consequently, it
is clear that Group I mGluRs activate MAPKs via multiple molecular pathways, thereby
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connecting extracellular and intracellular signals to genomic responses that are required
for long lasting changes in neuronal plasticity (Ferraguti et al., 1999).
1.2.4 Role of Group I Metabotropic Glutamate Receptors

When metabotropic glutamate receptors become stimulated by an agonist, such
as glutamate they produce signals that cause long-lasting changes in the cell (Dhami and
Ferguson, 2006; Gallagher et al., 2004; Kawabata et al., 1998). As a consequence,
Group I mGluRs are involved in the two classical forms of synaptic plasticity, long-term
depression (LTD) and long-term potentiation (LTP) (van Dam et al., 2004). LTD
induced by glutamate signalling involves a quick cellular response by NMDA receptors
while long-term maintenance is mediated by mGluRl/5 (Bashir et al., 1993; Clement et
al., 2009; van Dam et al., 2004). Studies have found that mice lacking mGluRl
experience a severe motor deficit due to loss of LTD induction in the cerebellum.
Additionally, these mice exhibited severe learning impairments, with an impaired mossy
fibre LTP (Conquet et al., 1994). Similarly, exposure to an mGluRl antagonist (S)-(+)alpha-amino-4-carboxy-2-methylbezeneacetic acid (LY 367385) impairs corticostriatal
LTD (Gubellini et al., 2001). Blockade of either mGluRl or mGluR5 has also prevented
LTP induction in hippocampal slices (Le Duigou and Kullmann, 2011).
Due to the effect Group I mGluRs have on synaptic plasticity, they have been
implicated in changes in synaptic activity that play a role in memory, learning, and
neurodegenerative diseases including; Huntington’s disease, amyotrophic lateral
sclerosis (ALS), and Alzheimer’s disease (Bordi and Ugolini, 1999; Byrnes et al., 2009;
Ribeiro et al., 2011; Riedel, 1996). Additionally, mGluRl/5 receptors are implicated in
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excitotoxicity caused by glutamate over-stimulation, which leads to neuronal cell death
and ischemia (Calabresi et al., 1999). However, the exact role Group I mGluRs play in
neuroprotection or neurodegeneration remain unclear (Pshenichkin et al., 2008).
mGluR5 has been shown to protect against excitotoxcity leading to cell death in
cerebellular neurons by decreasing NMDA-induced activation of nitric oxide synthase
(Llansola and Felipo, 2010). However, other studies have found that mGluRl/5
enhanced NMDA receptor mediated neuronal toxicity in cortical cells (Bruno et al.,
1995). Due to the effects Group I mGluRs have on synaptic plasticity, potential
therapeutics for neurological diseases are targeted towards these receptors. For example,
mGluRl antagonists (RS)-l-aminoindan-l,5-dicarboxylic acid (AIDA), 7(hydroxyimino)cyclopropa[b]chromen-la-carboxylate ethyl ester (CPCCOEt), and
LY367385 have been shown to reduce neuronal cell death in cortical cultures (Faden et
al., 2001). Similarly, mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine (MPEP)
and SIB-1893 have also been shown to reduce neuronal cell death in response to NMDA
exposure (O'Leary et al., 2000). However, the precise mechanisms that contribute to the
neuroprotective or neurotoxic effects of Group I Metabotropic Glutamate Receptors still
need to be defined.
1.2,5 The Regulation of G-protein Signalling

The signalling of Group I mGluRs is regulated at many levels under
physiological and pathological conditions, for example G-protein signalling is controlled
by Regulators of G-protein Signalling (RGS) proteins. RGS proteins terminate Gprotein signalling by acting as GTPase-activating proteins (GAPs) that accelerate Ga-
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GTP hydrolysis. The RGS proteins are divided into four groups based on sequence
homology, R4, R7, R12 and RZ. The R4 group contains RGS 1-5, 8, 13, 16, 18, and 21,
these proteins are able to function as GAP proteins and interact with other regulatory
proteins, including the third intracellular loop of GPCRs (Magalhaes et al., 2011).
RGS2 and RGS4 interact with Gaq/n proteins and therefore regulate mGluRl/5
signalling. Studies have found RGS4 to block Gaq/i i activation of phospholipase Cß and
mGluR5a inhibition of potassium currents in hippocampal neurons (Hepler et al., 1997;
Saugstad et al., 1998). Similarly, RGS2 has been shown interact with Gotj/n-GTP and
decrease mGluRla inhibition of potassium currents (Kammermeier and Ikeda, 1999).
The regulation of Group I mGluR signalling, trafficking and distribution is extremely
complex and involves many proteins, it is important to understand these mechanisms in
order to determine the role mGluR 1/5 play in the CNS.
1.3 GPCR Desensitization and Endocvtosis

GPCR signalling begins a feedback mechanism causing receptor desensitization
and endocytosis which protects against both acute and chronic receptor stimulation
(Ferguson, 2007). The classical model of desensitization involves uncoupling of the
GPCR and the G-proteins by receptor phosphorylation, this is mediated by secondmessenger protein kinases or G protein-coupled receptor kinases (GRKs). Second
messenger protein kinases, protein kinase C (PKC) or protein kinase A (PKA), can
phosphorylate both receptors exposed to agonist and non-agonist activated receptors,
which prevents subsequent activation. However, GRKs only phosphorylate the serine
and threonine resides in the third intracellular loop and carboxyl-terminal domains of
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agonist activated receptors (Ferguson, 2007). Upon GRK interaction, the receptor is
then stabilized in a conformation state that promotes the interaction of arrestins.
Arrestins preferentially bind to agonist activated and GRK-phosphorylated GPCRs.
Upon arrestin interaction, coupling to the G-protein is diminished and endocytosis
begins by targeting clathrin-coated vesicles to the receptor (Dale et al., 2001; Dale et al.,
2002; Ferguson et al., 1996; Ferguson, 2001; Ferguson, 2007). Upon endocytosis by
clathrin-coated vesicles, receptors can undergo resensitization by undergoing
dephosphorylation in endosomes and are subsequently recycled back to the cell surface.
Receptors may also be targeted for degradation in lysosomes which causes a down
regulation of receptor signalling (Figure 1.3) (Ferguson, 2001). However, metabotropic
glutamate receptors are unique from other GPCRs, in view of the fact that they undergo
both phosphorylation-dependent and -independent desensitization (Dhami and Ferguson,
2006).
1.3.1 Desensitization of Group I Metabotropic Glutamate Receptors
s
Group I mGluRs undergo various feedback mechanisms that protect against over
stimulation and cell death. Internalization can occur by multiple mechanisms depending
on the initiation of internalization and the splice variant (Dhami et al., 2002).
Additionally, signal attenuation can be mediated by a variety of second messengerdependent proteins including: PKC, calmodulin kinase II, GRKs, and optineurin
(Anborgh et al., 2005; Catania et al., 1991; Dale et al., 2000; Mundell et al., 2003).
mGluRl/5 desensitization is attenuated when PKC is inhibited, indicating an important
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Figure 1.3: Schematic of GPCR Desensitization and Resensitization. Upon GRK
phosphorylation, the receptor is then stabilized in a conformation state that promotes the
interaction of p-arrestin. Endocytosis begins by targeting clathrin-coated vesicles to the
receptor, where receptors can undergo resensitization by undergoing dephosphorylation
in endosomes and are subsequently recycled back to the cell surface. Receptors may also
be targeted for degradation in lysosomes which causes a down regulation of receptor
signalling (Dhami and Ferguson, 2006). Abbreviations: Parr, P-arrestin; E, effector
enzyme; G, heterotrimeric G protein; GRK, G protein-coupled receptor kinase; GRP, G
protein-coupled receptor phosphatase; H, hormone; P, phosphate group.
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role for PKC in mGluR desensitization. Interestingly, PKC appears to directly
phosphorylate mGluR 1 splice variants la and lc only (Dhami and Ferguson, 2006;
Mundell et al., 2003).
A number of GRKs have been found to mediate desensitization of mGluR 1/5,
including: GRK2, GRK4, GRK5 and GRK6 (Dale et al., 2000; Dhami and Ferguson,
2006). Studies have found that GRKs cause a reduction in mGluR 1/5 signalling and
block mGluR la-stimulated apoptosis in HEK 293 cells (Dale et al., 2000). Interestingly,
GRK2 can also cause desensitization of mGluR 1/5 through a phosphorylationindependent mechanism. A study found that the truncation of the mGluR 1a carboxyl
tail prevents receptor phosphorylation but not desensitization by GRK2 (Dhami et al.,
2002). Similarly, the splice variant mGluR lb, which contains a shorter C-tail than
mGluR la, is not phosphorylated by GRK2 but still undergoes GRK2 mediated
desensitization (Dhami et al., 2002). Phosphorylation-independent desensitization
occurs by GRK2 interaction on the second intracellular loop and C-tail of mGluR la, but
only requires an interaction with the second intracellular loop of mGluR lb (Dhami et al.,
2005).
GRK2 has an amino-terminal RGS homology (RH) domain, a central catalytic
domain and a carboxyl-terminal G(3y binding pleckstrin homology domain, allowing it to
interact with the receptor, Gaq/n, and GPy simultaneously, and thereby preventing
subsequent signalling cascades (Figure 1.4) (Ferguson, 2007). Furthermore, expression
of only the N-terminal domain of GRK2 has been shown to attenuate both constitutive
and agonist-dependent mGluR la and mGluR lb signalling (Dhami et al., 2002). The
GRK2 RH domain inhibits the signalling cascades induced by the Gaq/n protein by
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1)

2)

Figure 1.4: A Schematic Representation of GRK2 Mediated Desensitization of
Group I Metabotropic Glutamate Receptors. (1) The inactive receptor with the GaGDP protein bound. (2) The active receptor bound with the Ga-GTP protein, which
causes the G-protein to disassociate allowing GRK2 to interact with the receptor, the
Ga-GTP protein through the GRK2-RH domain, and the G(3y subunit. (3) GRK
interaction maintains the receptor in an inactivated state, preventing the Ga-GDP protein
to interact with the receptor. Abbreviations: GRK, G protein-coupled receptor kinases;
PLCp, phospholipase CP; RGS, Regulators of G-protein signalling (Ferguson, 2007).

interacting with it in an A1F4~- dependent matter and also functions as a weak GTPaseactivating protein (Carman et al., 1999; Dhami et al., 2002; Ferguson, 2007).
Phosphorylation-independent desensitization is a unique feature of Group I mGluRs,
thus providing a complex system in which mGluRl/5 signalling is regulated. In addition
to phosphorylation-independent desensitization, this GPCR family undergoes another
unique form of desensitization, constitutive internalization.

1.3.2 Constitutive Internalization

mGluRl/5 constitutive internalization is agonist and phosphorylation
independent, although the initiation and mediation of endocytosis remains unclear.
Recently, studies have found that the constitutive internalization of mGluRla is (3arrestin- and clathrin-dependent (Pula et al., 2004), although previous studies have
demonstrated that mGluRla constitutive internalization is mediated by clathrin-coated
vesicles but is p-arrestin and dynamin independent (Figure 1.5) (Dale et al., 2001).
Similarly, mGluR5a agonist-independent internalization also remains unknown, studies
have found that mGluR5a and mGluRla both co-localize with clathrin during agonistindependent internalization (Bhattacharya et al., 2004; Dale et al., 2001), yet it has been
suggested that mGluR5 constitutive internalization is not mediated by clathrin-coated
pits (Fourgeaud et al., 2003). Work from our laboratory has shown that mGluRl/5
constitutive internalization is P-arrestin-independent and is mediated by the association
with Ral (small GTP binding protein) and phospholipase D2 (PLD2). More specifically,
mGluR 1/5 has been shown to scaffold a protein complex containing Ral, Ral guanine
nucleotide exchange factor (RalGDS) and PLD2, and this complex appears to be a
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Figure 1.5: Schematic Representation of Agonist-stimulated and Constitutive
Endocytosis of mGluRla. 1) Group I mGluRs undergo the classical model of
desensitization that involves receptor phosphorylation, and subsequent p-arrestin
interaction. Upon P-arrestin interaction, endocytosis begins by clathrin-coated vesicles
targeted to the receptor. 2) Group I mGluR constitutive endocytosis is agonist and
phosphorylation independent, although the initiation and mediation of endocytosis
remains unclear. Studies have found that the constitutive internalization of mGluR la is
mediated by clathrin-coated vesicles but is P-arrestin and dynamin independent.
Abbreviations: Parr, P-arrestin; E, effector enzyme; G, heterotrimeric G protein; GRK, G
protein-coupled receptor kinase; GRP, G protein-coupled receptor phosphatase.
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necessary component for endocytosis in primary cortical neurons and human embryonic
kidney (HEK 293) cells (Bhattacharya et al., 2004). Nevertheless, mGluRl/5 undergoes
multiple forms of desensitization and it is important to understand them to fully
determine the role Group I mGluRs play in physiological and pathological conditions.
Group I mGluRs are unique from other GPCRs in their structure, signalling and
trafficking. These receptors play an important role in neuroprotection and
neurotoxicity, although the precise mechanism is still yet to be defined (Pshenichkin et
al., 2008). Additionally, interacting protein partners have been shown to alter the
signalling and may alter the physiological effects induced by Group I mGluRs (Croci et
al., 2003; Kammermeier and Ikeda, 2001; Kammermeier, 2008; Kitano et al., 2002;
Ronesi and Huber, 2008). A novel protein, spinophilin has recently been identified to
interact with Group I mGluRs and this novel protein may regulate the signalling and
trafficking of these receptors.
1.4 Spinophilin

Spinophilin is a scaffolding protein with multiple domains that is used to bring
protein partners into close proximity to respective substrates. Spinophilin was first
discovered in the heads dendritic spines and found to interact with protein phosphatase
1(PP1) a and y, thus it was called spinophilin (Allen et al., 1997). At the same time,
another group discovered the same protein to interact with actin filament (F-actin) with
similar organization to neurabin, thus it was named neurabin-II, which is now also called
spinophilin (Satoh et al., 1998). Spinophilin is closely related to and interacts with its
homologue neurabin, having 51% identical amino acids and 74% functional similarities
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(Sarrouilhe et al., 2006). In addition to an actin-binding domain and a protein
phosphatase 1 binding and regulatory domain, spinophilin also has a PSD-95/Discs
large/ZO-1 homology (PDZ) domain, a receptor-interacting domain, three putative Src
homology 3 domains, a potential leucine/isoleucine zipper motif and three coiled-coil
domains (Figure 1.6) (Sarrouilhe et al., 2006).
Spinophilin has been referred to as a scaffolding protein due to its many binding
domains, which allow it to mediate protein-protein interactions used for regulating
neuronal cell signalling. Recently, spinophilin has been found to interact with two
subfamilies of GPCRs; the dopamine receptors and the a-adrenergic receptors (Brady et
al., 2003; Sarrouilhe et al., 2006; Smith et al., 1999). Furthermore, spinophilin has been
found to scaffold other protein partners into close proximity to these receptors such as
RGS proteins 1, 2, 4 and 16 (Sarrouilhe et al., 2006; Wang et al., 2005). It is clear that
spinophilin has potential to alter cell signalling by mediating protein-protein
interactions, which demonstrates spinophilin’s important role in synaptic plasticity
(Table 1.1).
1.4.1 Spinophilin and Dendritic Spines

Dendritic spines are protrusions from the dendritic shaft that receive the majority
of excitatory signals in the central nervous system. Changes in number, size and shape
are associated with learning, development and changes in synaptic behaviour and
activity (Feng et al., 2000). Spinophilin plays an important role in organization and
intracellular transport in spine remodelling and morphology by stabilizing and bundling
F-actin (Hsieh-Wilson et al., 2003; Satoh et al., 1998). Studies have found that
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Figure 1.6: A Schematic Representation of the Binding Domains of Full Length
Spinophilin. Spinophilin is scaffolding protein that is able to mediate a variety of
protein-protein interactions. It is able to interact with F-actin through the actin binding
domain, GPCRs through the receptor interacting domain, and PDZ containing proteins
through the PDZ domain. Additionally, spinophilin interacts with and regulates protein
phosphatase 1 (PP1) through the PP1 binding site. Abbreviations: ABD, actin binding
domain; PP1BS, protein phosphatase 1 binding site; PDZ, PSD-95/Discs large/ZO-1
homology domain (Wang et al., 2005).
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Table 1.1: Proteins that Interact with or Co-localize with Spinophilin. Summary of
proteins that interact with or co-localize with spinophilin and the respective interacting
domain on spinophilin. Adapted from (Sarrouilhe et al., 2006).
1
Partner protein

Spinophilin motif

F-actin
Neurabin
Spinophilin
Doublecortin
DCAMKL1
PPla, PPip, PPlyl
-J
Oin
£

ABD l b
Coiled-coil domain
Coiled-coil domain
Coiled-coil domain
Coiled-coil domain
R-K-I-H-F motif
PDZ domain
Tiam 1
Amino acids 444-817
Ras-GRFl
Amino acids 444-817
Coiled-coil
domain
Lfc
RGS2
Amino acids 480-525
RGS1, RGS4, RGS 16
Unknown
GAIP
Unknown
Receptor binding domain
D2 dopamine receptor
ot1b—
»«2A-, a2B-5(X2c-Adrenergic receptors Receptor binding domain
RYR1, RYR2
LIZ motif
Unknown
TRPC5 and 6
ARF
Amino acids 605-726
TGN 38
Coiled-coil domain
r ......
Unknown
AMPA-type glutamate receptor
E-cadherin
Unknown
Abbreviations: ABD, actin binding domain; DCAMKL1, doublecortin and
-

^

calcium/calmodulin-dependent protein kinase-like 1; GRF, guanine nucleotide exchange
factor; Lfc, Lbc [lymphoid blast crisis]’s first cousin; LIZ, leucine/isoleucine zipper;
PDZ, postsynaptic density-95/discs large/zona occludens-1 motif; PP1, protein
phosphatase 1; RGS, regulator of G-protein signalling; RYR, ryanodine receptor;
TGN38, trans-Golgi network protein 38; TRP, the transient receptor potential.
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spinophilin deficient mice display an increase in spine density during development in
vivo and in vitro. Furthermore, spinophilin knockout mice display more protrusions
from the dendritic shafts but the same number of nerve terminals as wild type mice
(Feng et al., 2000). This indicates that spinophilin may regulate spine retraction or
decrease initial outgrowth of spines from the dendrite. Nevertheless, it is clear that
spinophilin plays an important role in the central nervous system by regulating spine
morphology and development.
1.4.2 Distribution of Spinophilin

Spinophilin is a ubiquitously expressed protein found in the spleen, lung, kidney,
and testis, but it is primarily expressed in the CNS. Spinophilin is primarily found in
the hippocampus, specifically the stratum oriens, stratum lacunosum- moleculare and
hilus (Allen et ah, 1997; Sarrouilhe et ah, 2006). Interestingly, the phosphorylation state
of spinophilin greatly affects its distribution in the CNS. Spinophilin has
phosphorylation sites for many kinases, including mitogen-activated protein kinase
ERK2, CaMKII, PKC and PKA. The consensus phosphorylation sites for these proteins
are within spinophilin’s actin binding domain, causing spinophilin to disassociate from
actin upon phosphorylation (Baucum et ah, 2010; Feng et ah, 2000; Hsieh-Wilson et ah,
2003). In rat spinophilin there are seven phosphorylation sites in the actin-binding
domain; Seri5 (ERK-site), Seri 7 (cyclin-dependent kinase 5 site), Ser94 [cAMPdependent protein kinase (PKA-site)], Seri00 (CaMKII-site), Seri 16 (CaMKII-site),
Seri 77 (PKA-site) and Ser205 (ERK-site) (Uematsu et ah, 2005). Upon
phosphorylation in the actin binding domain, spinophilin disassociates from actin and
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relocates so that it is no longer distributed in the dendritic spines (Grossman et al.,
2002). Upon CaMKII phosphorylation on Ser-100, spinophilin becomes enriched at the
synaptic plasma membrane but not in the post synaptic density (PSD) (Grossman et al.,
2004). Similarly, upon PKA phosphorylation on Ser-177, spinophilin relocates from the
PSD and becomes enriched in the cytosol (Hsieh-Wilson et al., 2003). Furthermore,
studies have found that spinophilin regulates GPCRs in a dephosphorylated state. For
example, PKA phosphorylation decreases the interaction between spinophilin and both
the 012-adrenergic receptor and F-actin (Xu et al., 2008). Interestingly, PKA
phosphorylation does not disrupt the interaction between spinophilin and protein
phosphatase 1 (PP1), which may provide a mechanism in which the spinophilin-PPl
complex relocates to regulate other protein partners (Hsieh-Wilson et al., 2003; Uematsu
et al., 2005).
1.4.3 Spinophilin and Protein Phosphatase 1

Protein phosphatase 1 is a serine/threonine phosphatase that is also located in the
dendritic spines, where it is involved in the regulation of hippocampal LTD and LTP
(Hsieh-Wilson et al., 1999; Morishita et al., 2001). Spinophilin has been shown to
anchor PP1 and bring it to close proximity to interacting proteins, causing a wide array
of secondary interactions (Ragusa et al., 2011). Three isoforms of PP1, PPla, PP1(3 and
P P lyl, interact with spinophilin on amino acid residues 417 to 494 (Allen et al., 1997;
Sarrouilhe et al., 2006). Spinophilin preferentially binds to the PPly subunit, which
upon interaction suppresses the phosphorylase phosphatase activity and thereby
inactivates PP1. Interestingly, PP1 also dephosphorylates spinophilin which regulates
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the function and distribution of spinophilin (Sarrouilhe et al., 2006; Uematsu et al.,
2005). Studies have found that spinophilin targets PP1 to respective substrates and
allows PP1 to dephosphorylate those proteins, indicating that spinophilin and PP1
interact transiently to allow the reactivation of PP1 (Hsieh-Wilson et al., 1999). For
example, spinophilin forms a complex with PP1, allowing it to interact and
dephosphorylate proteins and receptors including: actin, ionotropic glutamate receptors,
and dopamine receptors (Hsieh-Wilson et al., 1999; Ragusa et al., 2010).
1.4.4 Spinophilin and Glutamate Receptors

Spinophilin has been shown to regulate synaptic transmission by targeting PP1 to
ionotropic glutamate receptors including: N-methyl-D-aspartate receptor (NMDA) and
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
Spinophilin mediates the dephosphorylation of the AMPA and NMDA receptors by
anchoring PP1 to the postsynaptic densities (PSD) where the receptors are found, this
keeps the receptors in a low activity state (Feng et al., 2000; Yan et al., 1999). Studies
have found that the regulation of PP1 on NMDA receptors is diminished in spinophilin
knockouts (Feng et al., 2000), indicating that spinophilin is responsible for the
enrichment of PP1 in the PSD and contributes to the regulation of ionotropic glutamate
receptors.
1.4.5 Spinophilin and the a?-Adrenergic Receptors

The ci2-adrenergic receptors (012AR) are a family of GPCRs that are coupled to
the heterotrimeric Gdi/0proteins, which upon agonist stimulation cause the inhibition of
adenylyl cyclase and voltage gated calcium currents. Physiologically, 012AR stimulation
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results in lower blood pressure and a sedative, hypnotic effect (Lu et al., 2010). Unlike
Group I mGluRs, the 012AR only internalizes by receptor phosphorylation and
subsequent (3-arrestin interaction with the third intracellular loop. Therefore,
interactions that occur on the third intracellular loop are important for cell surface
retention or internalization (Wang and Limbird, 2002). Recently, studies have found
spinophilin to interact with all three subtypes of the a2-adrenergic receptors (o^ aAR,
(X2bAR, a2cAR) on the third intracellular loop (Brady et al., 2003; Sarrouilhe et al.,
2006). Upon (X2AR agonist stimulation, the Gai/0proteins disassociate and the Gpy
proteins become activated, spinophilin is then recruited to the plasma membrane where
it recognizes the 012AR- Gpy complex and interacts with the receptor (Brady et al., 2005;
Wang, Q., et al., 2004). Spinophilin competes against GRK2 for the third intracellular
loop, preventing receptor phosphorylation and subsequent p-arrestin interactions.
Therefore, spinophilin causes the (X2AR to remain on the plasma membrane, which
decreases receptor recycling, and the rate of receptor resensitization (Figure 1.7). In
addition to preventing internalization, spinophilin also decreases the acceleration of the
MAPK pathway initiated by P-arrestin-induced endocytosis (Wang, Q., et al., 2004).
Interestingly, Lu et al. (2010) found that spinophilin knockout mice display an
increased hypotensive, sedative, and hypnotic effect in response to 012AR stimulation.
These results suggest that deletion of spinophilin may cause an enhanced 012AR- G
protein coupling that causes the physiological effects observed. Furthermore, Lu et al.
(2010) found that spinophilin and arrestin dynamically regulate 012AR phosphorylation,
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Figure 1.7: Proposed Model of a-adrenergic Receptor Interactions with G-proteins,
Spinophilin, GRK and Arrestin. Spinophilin competes against GRK for the third
intracellular loop of the agonist activated a-adrenergic receptor. If spinophilin interacts
with the receptor first, it prevents receptor phosphorylation by GRK and subsequent Parrestin interaction, thereby decreasing receptor internalization and signal desensitization
(Wang, Q., et al., 2004). Abbreviations: parr, p-arrestin; GRK, G protein-coupled
receptor kinase.
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internalization, and signalling. They observed that mice lacking arrestin are more
resistant to sedation, while mice lacking spinophilin are more sensitive to sedation. This
indicates that spinophilin and P-arrestin dynamically regulate the 012AR under normal
physiological conditions. Thus, it is clear spinophilin plays an important role in
regulating the internalization and signalling cascades induced by the a2-adrenergic
receptors. Furthermore, spinophilin has been found to interact and regulate another
subfamily of the a-adrenergic receptors, the a iB-adrenergic receptor.
1.4.6 Spinophilin and the ai-Adrenergic Receptors

The aiB-adrenergic receptor (aiBAR) is coupled to the heterotrimeric GOq/n
protein, which upon agonist stimulation activates phospholipase C resulting in the
formation of IP3 and DAG, thereby causing the subsequent release of calcium from
intracellular stores. Recently, Wang et ai (2005) found that spinophilin interacts with
the third intracellular loop of the a iBAR, and regulates Gaq/n signalling by recruiting
RSG2 to the plasma membrane. As mentioned earlier, the Gaq/i 1 protein is regulated by
RGS2 which is a Gc^/n specific GTPase (Chen et al., 1997; Kammermeier and Ikeda,
1999). Spinophilin interacts with the a iBAR via the receptor interacting domain, tethers
the a iBAR to the cell surface via its coiled-coil domains and regulates the Go^ signalling
by interacting to the N-terminus of RGS2. Studies have found that the co-expression of
spinophilin with the a iBAR increases the maximum calcium current induced by receptor
stimulation but decreased the rate of activation and spontaneously inactivated signalling
with continuous stimulation. Additionally, spinophilin was found to be less effective in
regulating calcium currents in RGS2 deficient cells and RGS2 was less effective in
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inhibiting calcium currents in spinophilin knockout mice (Wang et ah, 2005; Wang, X.,
et ah, 2007). This indicates that spinophilin plays an important role in regulating the
signalling and trafficking of the am-adrenergic receptor, and provides a new mechanism
in which RGS2 regulates GPCRs.

1.4.7 Spinophilin and the Dopamine Receptors

There are five types of dopamine receptors and they are classified in two groups
based on the structure, function and pharmacology. Dl-like receptors (D1 and D5) are
coupled to heterotrimeric Gas proteins and have a short third cytoplasmic loop and long
a carboxyl-terminal tails. While, D2-like receptors (D2, D3 and D4) couple to
heterotri meric G y0 proteins and have a large third cytoplasmic loop and short carboxylterminal tails. Spinophilin has been found to interact to the third intracellular loop of the
D2 receptor in a yeast two hybrid assay and a GST pull down (Smith et al., 1999; Wang,
X., et al., 2007). However, very little research has been done to determine the relevance
of this interaction. One study found that chronic antipsychotic treatment targeted to D2
receptors significantly increased expression of spinophilin (Kabbani and Levenson,
2006), while another study found that D2 stimulation decreased the basal level of
phosphorylated-Ser94 spinophilin (Uematsu et al., 2005). Similarly, agonist stimulation
of D1 receptors causes signalling cascades that alter spinophilin function. Studies found
that agonist stimulation of D1 receptors increases PKA phosphorylation of Ser-94
spinophilin (Uematsu et al., 2005). Moreover, spinophilin knockout mice display a
diminished ability to phosphorylate AMPA receptors in response to D1 receptor
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activation (Allen et al., 2006). Thus, it is clear that spinophilin plays an important role
in dopamine signalling observed in physiological and pathological conditions.
1,4.8 Role of Spinophilin

Spinophilin is required for LTD, the regulation of receptors and channels and the
formation of dendritic spines (Sarrouilhe et al., 2006). Spinophilin knockout mice have
a small reduction in body weight, a reduced hippocampus and exhibit reduced LTD and
neuronal apoptosis (Feng et al., 2000). As a consequence, spinophilin has been linked to
many neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s
disease. In disease states such as AD, there is a deficit in higher order cognitive
processes, with a primary dysfunction in spines causing synaptic loss. A dysfunction in
spines can be attributed to changes in spine morphology, receptor distribution, and
changes in synaptic signalling; furthermore, these mechanisms have been shown to be
regulated by spinophilin (Feng et al., 2000; Hsieh-Wilson et al., 2003; Sarrouilhe et al.,
2006; Satoh et al., 1998). Similarly, Parkinson’s disease results in dopamine depletion,
which causes morphological alterations in striatal medium spiny neurons and
impairment of synaptic plasticity. Furthermore, studies have found that chronic striatal
dopamine depletion decreases PPly activity by increasing interaction with spinophilin
(Brown et al., 2008).
1.5 Goals and Significance of Research

As previously addressed, many studies have demonstrated that spinophilin has
the ability to interact with and regulate receptors found in the central nervous system
(Sarrouilhe et al., 2006). Studies have found that spinophilin interaction alters the
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signalling and trafficking of a-adrenergic receptors (Brady et al., 2005; Lu et al., 2010;
Wang et al., 2005). Similarly, spinophilin has been found to regulate ionotropic
glutamate receptors by mediating dephosphorylation through protein phosphatase 1
recruitment (Feng et al., 2000; Yan et al., 1999). Recently, our lab found spinophilin
using a tandem affinity purification proteomic screen to interact with the carboxyl tail of
mGluRla and mGluR5a. Furthermore, studies have revealed that the regulation of
Group I mGluR signalling is a dynamic process that involves a variety of proteins that
scaffold to the carboxyl-tail of mGluR 1/5 receptors (Kammermeier and Ikeda, 2001;
Kammermeier, 2008; Kitano et al., 2002; Ronesi and Huber, 2008). Interestingly, there
has yet to be an experiment that investigates whether spinophilin interacts with Group I
mGluRs and if this interaction regulates mGluR 1/5 signalling. Therefore, my thesis will
test the hypothesis that spinophilin associates with Group I mGluRs and this interaction
regulates the signalling and trafficking of these receptors.
Group I mGluR signalling has been implicated in a number of neurodegenerative
\

diseases including; Huntington’s disease, ALS and Alzheimer’s disease (Bordi and
Ugolini, 1999; Byrnes et al., 2009; Ribeiro et al., 2011; Wang, J., et al., 2004).
However, the exact role mGluRs play in neuroprotection or neurodegeneration remain
unclear (Pshenichkin et al., 2008). Thus, a clear understanding of how Group I mGluR
interacting proteins regulate receptor signalling is required for the development of novel
therapeutics targeted towards neurodegenerative diseases associated with mGluR 1/5
signalling.

31

CHAPTER 2
MATERIALS AND METHODS
2.1 Materials

Human embryonic kidney (HEK293) cells were obtained from the American
Type Culture Collection (Manassas, VA, USA). Tissue culture reagents, Alexa Fluor
555, Alexa Fluor 633 antibody labelling reagents, and GFP antibody were purchased
from Invitrogen (Burlington, ON, Canada). Quisqualate was purchased from Tocris
Cookson Inc. (Ellisville, MO, USA). EZ-Link Sulfo-NHS-SS-Biotin and immobilized
NeutrAvidin beads were from Pierce Biotechnology. The rabbit anti-mGluRl and mGluR5 antibodies are from Milipore. [myo-3H]Inositol was acquired from PerkinElmer
Life (Waltham, MA). Dowex 1-X8 (formate form) resin 200 to 400 mesh, DC protein
assay kit, horseradish peroxidase-conjugated anti-rabbit, and anti-goat IgG secondary
antibodies were from Bio-Rad Laboratories (Mississauga, ON, Canada). Goat antispinophilin antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
The protein G-Sepharose beads and chemiluminescence Western blotting detection
reagents were purchased from GE Healthcare (Oakville, ON, Canada). The spinophilin
cDNA clone was a kind gift from Dr. Wang (University of Alabama). Rabbit
polyclonal phospho-p42/44 MAP kinase (Thr202/Tyr402) and p42/44 MAP kinase were
obtained from Cell Signaling Technology (Pickering, ON, Canada). The rabbit antiFLAG antibody and all other biochemical reagents were purchased from Sigma-Aldrich
(St. Louis, MO).
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2.2 Cell Culture

HEK 293 cells were maintained in Eagle's minimal essential medium
supplemented with 10% (v/v) heat inactivated fetal bovine serum (Invitrogen,
Burlington, ON, Canada) and 50 pg/ml gentamicin. Cells seeded in 100-mm dishes were
transfected using a modified calcium phosphate method with cDNA as indicated in the
Figure Legends. After transfection (18 h), cells were washed with phosphate buffered
saline (PBS), pooled and reseeded on appropriate dishes.
Primary neuronal cultures were prepared from the hippocampus of embryonic
day 18 CD1 mouse embryos. Cells were plated on 15 mm glass coverslips coated with
poly-L-omithine (Invitrogen) in Neurobasal media with B-27 (Gibco) and N2 (Gibco)
supplements, 2 mM glutamax, 50 pg/ml penicillin, and 50 mg/ml streptomycin for 5 h at
37°C and 5% CO2 in a humidified incubator to permit cell attachment. Neurobasal
medium was subsequently replaced with culture medium that was replenished every 3
days, cells were cultured for up to 21 days in vitro. Culture medium consisted of
Neurobasal medium supplemented with B27, 0.5 U/mL penicillin, 0.05 mg/mL
streptomycin, 10 pm MK-801, 25 mm KC1 and 5 pg/mL glial-derived neurotrophic
factor. All animal procedures were approved by the University of Western Ontario
Animal Care Committee.
2.3 Cell Transfection

HEK 293 cells were transfected using a modified calcium phosphate method in
100 mm dishes. 2 pg of cDNA indicated in Figure Legends was added to 450 pL sterile
distilled water, followed by the addition of 50 pL 2.5 M CaCE. Then 500 pL of 2X
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HEPES-balanced salt solution (16.4 g NaCl, 0.38 M final; 11.9 g HEPES, 0.05 M final;
0.21 g Na2HPC>4, 1.5 mM final) was added drop-wise to the mixture. The final mixture
was added drop-wise across the surface of the 100-mm cell culture dish. The cells were
incubated with the transfection overnight at 37°C in a humidified atmosphere of 95%
air, 5% CO2.
Hippocampal neurons were transfected using a modified calcium phosphate
method in 15 mm glass coverslips. 4 pg of cDNA indicated in Figure Legends was
added to 23 pL sterile distilled water, followed by the addition of 2.25 pL 2 M CaCl2.
Then 22.3 pL of 2X HEPES-balanced salt solution was added drop-wise to the mixture.
The reaction was allowed to precipitate for 20 minutes in the dark. The final mixture
was added drop-wise across the surface of the cell culture dishes containing only
neurobasal medium. The cells were incubated with the transfection for 20-60 minutes at
37°C in a humidified atmosphere of 95% air, 5% CO2. After incubation the transfection
was washed off by changing the medium and experiments were performed the next day.
s
2.4 Co-immunoprecipitation

HEK 293 cells were transiently transfected with various cDNA constructs as
described in the Figure Legends. After transfection, the cells were incubated for 5, 10,
15 min in HEPES-buffered saline solution (HBSS) at 37°C with or without 30 pM of
quisqualate as indicated in the Figure Legends. The cells were then placed on ice,
washed twice with ice-cold phosphate-buffered saline (PBS), and lysed with ice-cold
lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, and 0.1% Triton X-100) containing
protease inhibitors (1 mM AEBSF, 10 pg/ml leupeptin, and 5 pg/ml aprotinin). The
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lysates were placed on a rocking platform for 15 min at 4°C and centrifuged at 15,000
RPM for 15 min at 4°C to pellet insoluble material. Cleared supernatant containing 2501000 pg of protein were incubated with 25 pi of Protein G Sepharose beads (GE
Healthcare) containing either anti-mGluRl or -mGluR5 antibodies (Milipore) for 1 h
rotating at 4°C to immunoprecipitate the receptor. After incubation, the beads were
washed three times with PBS, and proteins were solubilised in a 3x SDS sample buffer
containing 2-mercaptoethanol. Samples were separated by SDS-PAGE, transferred to a
nitrocellulose membrane, and immunoblotted to identify co-immunoprecipitated GFPtagged spinophilin using a primary polyclonal rabbit anti-GFP (1:1000 dilution;
Invitrogen/Molecular Probes) followed by a horseradish peroxidase-conjugated
secondary anti-rabbit antibody (1:10,000; Bio-Rad). Receptor and spinophilin protein
expression was determined by immunoblotting 10 pg of protein from each cell lysate
used for immunoprécipitation. Proteins were detected using chemiluminescence with the
enhanced chemiluminescence kit from GE Healthcare.
2.5 Immunofluorescence Confocal Microscopy

Confocal microscopy was performed using a Zeiss LSM-510 laser scanning
microscope equipped with a Zeiss 63x 1.4 numerical aperture oil immersion lens (Carl
Zeiss Inc., Thomwood. NJ). Live-cell imaging was performed on HEK 293 cells in
untreated 35-mm glass-bottomed plates. Cells were kept at 37°C using a heated
microscope stage. mGluRla/5a was labelled with rabbit anti-FLAG (Sigma-Aldrich)conjugated Zenon Alexa Fluor 555 antibody (Invitrogen). Receptor was stimulated with
the addition of 30 pM of quisqualate (final concentration). Visualization of antibody-
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labelled receptor with GFP-spinophilin was performed by dual excitation (488/543 nm)
and emission band pass from 505 to 530 (GFP) and long pass at 560 (Alexa Fluor 555)
filter sets.
Live imaging was performed on primary hippocampal cultures in 15-mm glass
coverslips. Cells were kept at 37°C using a heated microscope stage. mGluR5 was
labelled with rabbit anti-FLAG (Sigma-Aldrich)-conjugated Zenon Alexa Fluor 555
antibody (Invitrogen). Visualization of antibody-labelled receptor with GFP-spinophilin
was performed by dual excitation (488/543 nm) and emission band pass from 505 to 530
(GFP) and long pass at 560 (Alexa Fluor 555) filter sets.
2.6 Internalization Assay

HEK 293 cells transfected with 2 pg of FLAG-mGluRla/5a and either 2 pg of
GFP or GFP-spinophilin were incubated with HBSS for one hour at 37°C. The cells
were then washed with and incubated for 20 min on ice in HBSS, then incubated with
0.5 mg/ml sulfo-NHS-SS-biotin (Pierce Biotechnology) in HBSS for 1 h on ice to
biotinylate cell surface proteins. Biotinylation was quenched by incubating cells with
100 mM glycine in HBSS for 30 min on ice. Cells were washed again with HBSS, then
incubated for 5 and 15 min in HEPES-buffered saline solution (HBSS) at 37°C with 30
pM of quisqualate (Tocris), to cause internalization. Cells were then returned to ice to
stop mGluRla/5a internalization. To measure biotin bound to mGluRla/5a that has
internalized, residual biotin bound to membrane proteins that remained at the cell
surface was removed by incubating cells with 100 mM sodium 2mercaptoethanesulfonate (MesNa) in HBSS for 45 min. Cells were then washed three

times with HBSS, then lysed with ice-cold lysis buffer (50 mM Tris, pH 8.0, 150 mM
NaCl, and 0.1% Triton X-100) containing protease inhibitors (1 mM AEBSF, 10 pg/ml
leupeptin, and 5 pg/ml aprotinin). Lysates were centrifuged at 15 000 RPM for 15 min
at 4 °C, then equal amounts of protein from each sample were incubated with
Neutravidin beads (Pierce Biotechnology) for 1.5 h at 4 °C. After incubation, the beads
were washed three times with PBS, and proteins were solubilized in a 3x SDS sample
buffer containing 2-mercaptoethanol. Samples were separated by SDS-PAGE,
transferred to a nitrocellulose membrane, and immunoblotted for mGluRla/5a. Cells
subjected to biotinylation, but not incubated at 37 °C to allow receptor internalization,
underwent treatment with MesNa as a control to assess biotin stripping efficiency. Cells
that were biotinylated, but not stimulated and not stripped with MesNa were a positive
control to show total plasma membrane receptor.
2.7 Inositol phosphate formation

HEK293 cells were transiently transfected with 2 pg of FLAG-mGluRla and
with 2 pg of either GFP or GFP-spinophilin. Forty-eight hours after transfection, inositol
lipids were radiolabeled by incubating HEK293 cells overnight with 1 pCi/ml [3H]myoinositol (PerkinElmer Life) in Dulbecco's modified Eagle's medium (Invitrogen).
Unincorporated [3H]myo-inositol was removed by washing the HEK293 cells with
HBSS. HEK293 cells were then preincubated for 1 hr in HBSS at 37°C and then
preincubated in 500 pi of HBSS containing 10 mM LiCl for an additional 10 min at
37°C. HEK293 cells were subsequently treated in either the absence or the presence of
increasing concentrations (0-100 pM) of quisqualate (Tocris) for 30 min at 37°C. The
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reaction was stopped on ice by adding 500 pi of 0.8 M perchloric acid and then
neutralized with 400 pi of 0.72 M KOH and 0.6 M KHC03. The total [3H]myo-inositol
incorporated into the cells was determined by counting the radioactivity present in 50 pi
of the cell lysate. Total inositol phosphate was purified from the cell extracts by anion
exchange chromatography using Dowex 1-X8 (formate form) 200-400 mesh anion
exchange resin (Bio-Rad). [3H] Inositol phosphate formation was determined by liquid
scintillation using a Beckman LS 6500 scintillation system (LS 6500; Beckman Coulter,
Fullerton, CA).
2.8 ERK1/2 immunoblots

HEK293 cells were transiently transfected with 2 pg of FLAG-mGluRla with 2
pg of either GFP or GFP-spinophilin. The cells were then stimulated for 0, 2, 5, 10 and
15 minutes with 30 pM of quisqualate. Following stimulation, the cells were placed on
ice and washed with cold PBS. The cells were lysed using with ice-cold lysis buffer (50
mM Tris, pH 8.0, 150 mM NaCl, and 0.1% Triton X-100) containing protease and
phosphatase inhibitors (1 mM AEBSF, 10 pg/ml leupeptin, and 5 pg/ml aprotinin, 1 M
NaF, 100 pM Na^VO/*). The cells were incubated with the lysis buffer for 15 minutes at
4°C and centrifuged at 15000 RPM for 15 minutes to pellet insoluble material. The
protein content of 50 pg samples of cell lysate was determined using a protein assay kit
(Bio-Rad). The lysates were then solubilized in a 3x SDS sample buffer containing 2mercaptoethanol. Samples were separated by SDS-PAGE, transferred to a nitrocellulose
membrane, and immunoblotted for phospho-p42/44 MAP kinase (Thr202/Tyr402)
antibody (diluted 1:1000), p42/44 MAP kinase antibody (1:1000) (Cell Signalling),

38

rabbit anti-Flag antibody (1:1000) (Sigma) and goat anti-spinophilin (1:200) (Santa
Cruz).
2.9 Immunoblotting

Membranes were blocked with 10% milk in wash buffer (150 mM NaCl, 10 mM
Tris-HCl, pH 7.0, and 0.05% Tween 20) for 1 h and then incubated overnight with
antibodies stated above in wash buffer containing 3% milk. Membranes were rinsed
three times with wash buffer and then incubated with secondary horseradish peroxidaseconjugated goat anti-rabbit IgG (1:10,000), and rabbit anti-goat IgG (1:2500) (Bio-Rad)
in wash buffer containing 3% skim milk for 1 h. Membranes were rinsed three times
with wash buffer and incubated with enhanced chemiluminescence Western blotting
detection reagents (GE Healthcare).
2.10 Statistical Analysis

The means ± S.E.M. are shown for values obtained for the number of
independent experiments indicated in the Figure Legends. Quantification of
immunoblots of biotinylated receptors was performed using Scion Imaging using
immunoblots of similar exposures, and data expressed as mean pixel intensity.
GraphPad Prism software (Graph Pad, San Diego, CA) was used to analyze data for
statistical significance, as well as to analyze and fit dose-response and time course data.
The statistical significance was determined by either an unpaired two tailed t-test, or by
one-way ANOVA analysis of variance followed by Dunnett’s multiple comparison test.
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CHAPTER 3
RESULTS
3.1 Identification of Spinophilin as a Group I Metabotropic Glutamate Receptor
interacting Protein

We used the carboxyl tails (C-tails) of mGluRla and mGluR5a to identify Group
I mGuR-interacting proteins in a tandem affinity purification proteomic screen and
identified spinophilin as a novel interactor. In addition to spinophilin, we identified
PPly, Homerlb, Homer2, Homer 3 and GIPC as mGluRla/5a-interacting proteins. The
mGluRla and mGluR5a -C tails were previously shown to bind phosphatase ly (PPly),
Siah-1 A, Homer and tamalin, a PDZ domain containing protein (Croci et al., 2003;
Kammermeier and Ikeda, 2001; Kammermeier, 2008; Kitano et al., 2002; Ronesi and
Huber, 2008). The mGluRla/5a C-tails encode both PPly and PDZ binding motifs and
spinophilin encodes a PDZ domain and is the regulatory subunit for protein phosphatase
ly (Hsieh-Wilson et al., 1999; Sarrouilhe et al., 2006). Therefore, we first tested
whether spinophilin could be co-immunoprecipitated with either mGluRla or mGluR5a.
We found that GFP epitope-tagged spinophilin was co-immunoprecipitated from HEK
293 cells transiently transfected with either FLAG-tagged mGluRla or mGluR5 and
GFP-spinophilin (Figure 3.1). This confirmed that spinophilin was an mGluRla- and
mGluR5a-interacting protein.
Previous studies found that spinophilin was recruited to the a2-adrenergic
receptor in response to agonist stimulation (Brady et al., 2003; Brady et al., 2005).
Therefore we examined whether agonist treatment increased the association between
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Figure 3.1: Co-immunoprecipitation of Spinophilin with Group I mGluRs. Western
blots demonstrating the co-immunoprecipitation of GFP-spinophilin with FLAGmGluRla and FLAG-mGluR5a in FIEK 293 cells. Western blots also demonstrate the
expression of receptors and spinophilin from cell lysates with anti-mGluRl, antimGluR5 and anti-GFP antibodies. FIEK 293 cells were transfected with 2 pg of GFPspinophilin along with either 2 pg of FLAG-mGluRla and FLAG-mGluR5a cDNA.
The data is representative of 3 independent experiments.
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spinophilin and mGluRl/5 by co-immunoprecipitation. Although we consistently
observed an association between GFP-spinophilin and both FLAG-mGLuRla and
FLAG-mGluR5a, the extent of the interaction varied following agonist stimulation
(Figure 3.2). This indicated that the association between spinophilin and mGluRl/5 may
be transient.
3.2 Subcellular Localization of Spinophilin, mGluRla and mGluR5a in HEK 293
cells

It is well established that spinophilin interacts with and bundles F-actin
(Stephens and Banting, 2000). Therefore, to ensure that GFP-spinophilin was
appropriately localized in HEK 293 cells, we transfected GFP-spinophilin in HEK 293
cells and stained for actin (phalloidin). These cells were then imaged by confocal
microscopy. We found that spinophilin and actin were clearly co-localized in HEK 293
cells (Figure 3.3). Previous studies demonstrated that spinophilin co-localized with the
012-adrenergic receptor on the cell surface of polarized Madin-Darby canine kidney cells
\
(Brady et al., 2003). Therefore, we examined the subcellular localization of GFPspinophilin in cells co-expressing FLAG-mGluRla or FLAG-mGluR5a. We found that
the co-expression of both FLAG-mGluRla (Figure 3.4A) and FLAG-mGluR5a (Figure
3.4B) increased the localization of GFP-spinophilin at the cell surface.
3.3 Co-localization of Spinophilin and mGluR5 in Hippocampal Neurons

To further determine the subcellular localization of spinophilin, hippocampal
neurons were transfected to over-express GFP-spinophilin and red fluorescence protein
(RFP) as a non-specific protein to fill the processes in neurons allowing a clear
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Figure 3.2: Co-immunoprecipitation of Spinophilin with Group I mGluRs During
Agonist Stimulation. (A) Western blots demonstrating the immunoprécipitation of the
receptors FLAG-mGluRla and the co-immunoprecipitation of GFP-spinophilin in HEK
293 cells with 30 pM of quisqualate stimulation for 0, 5, 15 minutes. Western blots also
demonstrate the expression of receptors and spinophilin from cell lysates with antimGluRl and anti-GFP antibodies. (B) Western blots demonstrating the
immunoprécipitation of the receptors FLAG-mGluR5a and the co-immunoprecipitation
of GFP-spinophilin in HEK 293 cells with 30 pM of quisqualate stimulation for 0, 5, 15
minutes. Western blots also demonstrate the expression of receptors and spinophilin
from cell lysates with anti-mGluR5 and anti-GFP antibodies. HEK 293 cells were
transfected with 2 pg of GFP-spinophilin along with either 2 pg of FLAG-mGluRla and
FLAG-mGluR5a cDNA. The data is representative of 3 independent experiments.
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Figure 3.3: Expression of Spinophilin in HEK 293 Cells. Confocal images of GFPspinophilin (green), phalloidin (red), Hoechst (blue), and co-localization (yellow). HEK
293 cells were transfected with 2 pg of GFP-spinophilin and labelled with phalloidin and
Hoechst and visualized using confocal microscopy. The data is representative of 3
experiments. Scale bars, 10 pm.
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Figure 3.4: Expression of Spinophilin and Group I mGluRs in HEK 293 Cells. (A)
Confocal images of live HEK 293 cells transfected with GFP-spinophilin (green) and
FLAG-mGluRla (red). Co-localization is indicated in the overlay images (yellow). (B)
Confocal images of live HEK 293 cells transfected with expressing GFP-spinophilin
(green) and FLAG-mGluR5a (red). Co-localization is indicated in the overlay images
(yellow). Cells are transfected with 2 pg of cDNA encoding GFP-spinophilin and 2 pg
of cDNA encoding either FLAG-mGluRla or FLAG-mGluR5a and are stained with
Alexa Fluor-conjugated 555 rabbit polyclonal antibody at 4°C. The data is
representative of 5 experiments. Scale bars, 10 pm.
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indication of the spines. GFP-spinophilin was found to be primarily localized within
synaptic spines in hippocampal neuronal dendrites (Figure 3.5A). To determine whether
GFP-spinophilin was co-localized with Group I mGluRs at synaptic densities,
hippocampal neurons were transfected to express both FLAG-mGluR5a and GFPspinophilin. Live neurons expressing FLAG-mGluR5a were labelled with Alexa Fluor
555-conjugated FLAG antibody. Consistent with the observation that spinophilin co
localizes with mGluRl/5 in HEK 293 cells, co-localization of the mGluR5 and
spinophilin was found along the dendritic processes (Figure 3.5B). The data indicates
that spinophilin co-localizes with mGluR5 in the dendritic spines of transfected
hippocampal neurons.
3.4 Agonist-stimulated mGIuR5a and Spinophilin Internalization

Spinophilin was previously shown to be recruited to the plasma membrane after
a2AR agonist stimulation, where it then recognizes the activated a2AR- G(3y complex
and tethers the receptor to the plasma membrane (Brady et al., 2003; Brady et al., 2005).
Additionally, spinophilin could be co-immunoprecipitated with both mGluRla and
mGluR5a and was co-localized with both receptors. Therefore, we tested whether
spinophilin over-expression altered agonist-mediated internalization of mGluRla and
mGluR5a using a cell surface biotinylation assay. To determine the extent of
mGluRla/5a internalization, cell-surface proteins were biotinylated on ice, warmed to
37 °C, and treated with 30 pM quisqualate for 0, 5, 15 min. The internalization of
mGluRla/5a in response to agonist was determined as the proportion of total
biotinylated receptor that was resistant to MESNA stripping following agonist treatment.
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Figure 3.5: Spinophilin is Expressed Primarily along the Spines in Primary Mouse
Hippocampal Neurons. (A) Confocal images of live mouse hippocampal neurons
transfected with GFP- spinophilin (green) and red fluorescence protein (red). (B)
Confocal images of live mouse hippocampal neurons transfected with GFP-spinophilin
(green) and FLAG-mGluR5a labelled with Alexafluor 555 conjugated FLAG antibody
(red). Co-localization is shown in the overlay image (yellow). Neurons transfected
with 4 pg of cDNA encoding GFP-spinophilin, and either 2 pg of cDNA encoding red
fluorescence protein or 4 pg of FLAG-mGluR5a cDNA were imaged by confocal
microscopy. The data is representative of 3 experiments. Scale bars, 10 pm.
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We found that, the internalization of FLAG-mGluRla was significantly reduced in the
presence of GFP- spinophilin following 5 minutes of agonist treatment (30 pM
quisqualate), but was not significantly different from GFP transfected control at 15
minutes (Figure 3.6). In contrast, the internalization of FLAG-mGluR5a was not
significantly reduced in the presence of GFP-spinophilin following 5 minutes of agonist
treatment (30 pM quisqualate), but exhibited a trend towards reduced internalization
following 15 minutes agonist treatment (Figure 3.7). Thus, similar to what was
previously observed for the (X2AR, spinophilin antagonized FLAG-mGluRla
internalization.
3.5 Effect of Spinophilin on mGluRla-mediated Signalling in HEK 293 cells

It is well established that Group I mGluRs activate the heterotrimeric Gaq/n
protein which leads to the activation of phospholipase C, causing the formation of
inositol 1, 4, 5 trisphosphate (IP3) and diacylglycerol (DAG), which subsequently causes
the release of calcium from intracellular stores (Kawabata et al., 1998). Spinophilin has
been found to interact with the am - adrenergic receptor (a^AR), which is also coupled
to the heterotri meric Gaq/n protein, and functions to enhance amAR-stimulated calcium
currents by attenuating a^A R endocytosis (Wang et al., 2005). We have shown that
spinophilin decreases mGluRla internalization following 5 minutes of agonist
stimulation, therefore, we examined whether the GFP-spinophilin over-expression leads
to an alteration of FLAG-mGluRla-mediated inositol phosphate (IP) formation. In the
absence of GFP-spinophilin, increasing amounts of quisqualate treatment on HEK 293
cells over-expressed with FLAG-mGluR 1 resulted in a dose-dependent increase
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Figure 3.6: Internalization of mGluRla with Spinophilin. (A) Shown is a
representative immunoblot demonstrating the agonist-stimulated internalization of
FLAG-mGluRla in the presence of either GFP or GFP-spinophilin following 5 and 15
minutes of agonist treatment with 30 pM quisqualate. (B) Densitometry analysis of the
immunoblot showing the extent of loss of cell surface protein expression. The data
represents the mean ± the SEM for 6 independent experiments. *P<0.05, two-tailed
unpaired t-test.
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Figure 3.7: Internalization of mGluR5a with Spinophilin. (A) Shown is a
representative immunoblot demonstrating the agonist-stimulated internalization of
FLAG-mGluR5a in the presence of either GFP or GFP-spinophilin following 5 and 15
minutes of agonist treatment with 30 pM quisqualate. (B) Densitometry analysis of the
immunoblot showing the extent of loss of cell surface FLAG-mGluR5a protein
expression. The data represents the mean ± the SEM for 5 independent experiments.
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in IP accumulation over 30 minutes. In HEK 293 cells over-expressing GFP-spinophilin
and FLAG-mGluRla, the dose-dependent increase in IP accumulation is not altered
(Figure 3.8). This data indicates that spinophilin interaction does not alter mGluRla Gprotein coupling.
In addition to causing the release of calcium from intracellular stores, the
activation of the heterotrimeric Gaq/n protein by mGluRl/5 also couples the receptors to
the activation of other downstream effector enzymes (Nicodemo et al., 2010) and this
might require mGluRla endocytosis. Group I mGluRs activate ERK1/2 through
multiple mechanisms, but one mechanism is thought to involve P-arrestin internalization
of mGluRla (Emery et al., 2010; Iacovelli et al., 2003; Wang, J., et al., 2007).
Therefore, we tested whether GFP-spinophilin might alter mGluRla-stimulated ERK1/2
phosphorylation. We find that the over-expression of GFP-spinophilin results in a
significant decrease in FLAG-mGluRla-stimulated ERK1/2 phosphorylation following
2, 5, 10 and 15 minutes stimulation of mGluRla with quisqualate (Figure 3.9). Thus,
\
spinophilin over-expression selectively attenuates mGluR la-mediated ERK1/2
phosphorylation without affecting receptor G-protein coupling.
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Figure 3.8: Effect of Spinophilin on Agonist-stimulated mGluRla Inositol
Phosphate Formation. (A) mGluRl -stimulated inositol phosphate formation in
response to treatment with increasing concentrations of quisqualate for 30 min in the
presence of either GFP or GFP-spinophilin. The log EC50 for mGluRl is -7.058 and the
log EC™ for mGluRl and spinophilin is -7.033. (B) Immunoblot showing equivalent
FLAG-mGluRla expression in GFP and GFP-spinophilin transfected HEK 293 cells.
The data represents the mean ± the SEM for 6 independent experiments.
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Figure 3.9: Effect of GFP-spinophilin Over-expression on mGluRla-stimulated
ERK1/2 Phosphorylation. (A) Representative immunoblot for FLAG-mGluRla
stimulated ERK 1/2 phosphorylation in response to 30 pM quisqualate stimulation for 0,
2, 5, 10 and 15 min in the presence of either GFP or GFP-spinophilin. Shown are
immunoblots for phosphorylated (p-ERK) and total ERK. (B) Densitometry analysis of
the immunoblots showing the mean ± SD of the change in ERK1/2 phosphorylation for
6 independent experiments. *P<0.05, ANOVA followed by paired t-test.
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CHAPTER 4
DISCUSSION
4.1 Identification of Spinophilin as a Group I mGluR Regulatory Protein

Glutamate is the major excitatory neurotransmitter in the brain and is essential
for many physiological processes, including integrative brain function and neuronal cell
development (Bordi and Ugolini, 1999; Nakanishi, 1994). Glutamate mediates its
functions through a variety of ionotropic and metabotropic glutamate receptors
(Nakanishi, 1994). Group I mGluRs modulate synaptic efficacy by coupling to multiple
second messenger cascades through the heterotrimeric Goq/n protein (Dhami and
Ferguson, 2006; Kawabata et al., 1998; Wang, J., et al., 2007). Additionally, the
activation of these receptors has been implicated in a number of neurodegenerative
diseases including: Huntington’s disease, ALS and Alzheimer’s disease (Bordi and
Ugolini, 1999; Byrnes et al., 2009; Ribeiro et al., 2011; Wang, J., et al., 2004).
However, the exact role that mGluRs play in both neuroprotection and
neurodegeneration remain unclear (Pshenichkin et al., 2008).
Protein-protein interactions have been shown to play an important role in
regulating Group I mGluR signal transduction in the central nervous system and it is
now established that mGluR la and mGuR5a act as molecular scaffolds for the
recruitment of multiple regulatory signalling complexes. For example, mGluR la and
mGluR5a have been shown to interact with phosphatase ly, Siah-1 A, Homer and PDZ
proteins. Furthermore, these interactions play an important role in the regulation of
Group I mGluR signalling cascades (Croci et al., 2003; Kammermeier and Ikeda, 2001;
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Kammermeier, 2008; Kitano et al., 2002; Ronesi and Huber, 2008). We have found a
new Group I-interacting protein, spinophilin that binds to both the mGluRla and
mGluR5a C-tails. Spinophilin has been shown to regulate ionotropic glutamate
receptors through protein phosphatase 1 (PPly), as well as interact with a number of
GPCRs through a receptor interacting domain (Sarrouilhe et al., 2006; Smith et al.,
1999; Uematsu et al., 2005; Wang et al., 2005; Yan et al., 1999). Furthermore,
spinophilin encodes a PDZ domain, which may mediate the interaction with
mGluRla/5a (Sarrouilhe et al., 2006). Similarly, Group I mGluRs have a PPly domain
and a PDZ domain at the end of their C-tails (Croci et al., 2003; Kitano et al., 2002).
Therefore, the purpose of this thesis was to determine if spinophilin interacts with
mGluRla and mGluR5a and to examine whether this interaction is of importance for
regulating both mGluRla and mGluR5a trafficking and signalling.
A clear understanding of how Group I mGluR interacting proteins regulate
receptor signalling is required for the development of effective therapeutics to treat
neurodegenerative diseases associated with mGluRla/5a signalling. In attempt to
determine the potential role spinophilin has in the regulation of Group I mGluR
signalling and internalization, we have made several key observations: 1) spinophilin
associates with mGluRla and mGluR5a and this association may be dynamically
regulated by agonist activation, 2) spinophilin antagonizes agonist-stimulated mGluRla
internalization , 3) spinophilin does not alter inositol phosphate formation induced by
mGluRla stimulation, and 4) spinophilin prevents ERK1/2 phosphorylation in response
to mGluRla activation.
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4.2 Interaction between Spinophilin and Group I mGluRs

Group I mGluRs function as molecular scaffolds for the recruitment of
intracellular and extracellular signalling complexes. mGluRl splice variants (a-d) and
mGluR5 splice variants (a and b) are of variable length and therefore function differently
and interact with distinct protein complexes. mGluRla and mGluR5a have extremely
long C-tails that are known to interact with several proteins including: protein
phosphatase ly, Siah-1 A, Homer and PDZ proteins. In contrast, mGluRl and mGluR5
splice variants lack the extended C-tails and thus do not have the capacity to mediate the
essential protein interactions required for Group I mGluR-dependent neuronal plasticity
(Croci et al., 2003; Kammermeier and Ikeda, 2001; Kammermeier, 2008; Kitano et al.,
2002; Ronesi and Huber, 2008). For example, protein phosphatase 1 (PPly) has been
shown to regulate mGluRl/5-mediated ERK1/2 phosphorylation (Voulalas et al., 2005).
Additionally, PPly has been shown to interact with AMPA receptors, and regulates their
low activity state by allowing their déphosphorylation (Yan et al., 1999). The
recruitment of PPly to ionotropic glutamate receptors is also mediated by spinophilin,
which recruits PPly to these receptors and also regulates PPly catalytic activity (HsiehWilson et al., 1999; Ragusa et al., 2011 ; Yan et al., 1999). Thus, spinophilin has the
capacity to regulate post synaptic receptors by recruiting enzymes to the receptor
complex.
Work done in our laboratory has identified spinophilin, using a tandem affinity
purification proteomic screen, as a protein that interacts with the carboxyl tails of
mGluRl a and mGluR5a. To confirm these findings, our initial experiments tested
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whether spinophilin associated with both mGluRla and mGluR5a. We observed that
GFP epitope-tagged spinophilin co-immunoprecipitated with both FLAG-tagged
mGluRla and -mGluR5a. There are two potential mechanisms by which spinophilin
may interact with mGluRla and mGluR5a. Spinophilin either forms a protein complex
with PPly that is scaffolded to the Group I mGluR PPly binding motif or the spinophilin
PDZ domain interacts directly with the mGluRla and mGluR5a PDZ C-tail binding
motifs. Further analysis of the mechanisms underlying the interaction between
spinophilin and Group I mGluRs, will require the mutation of both the PPly and PDZ
motifs in the mGluRla and mGluR5a C-tails and the investigation of spinophilin
interactions with mGluR lb which lacks these motifs. Similarly, co-immunoprecipitation
experiments with spinophilin, PPly and mGluRl/5 need to be conducted. This will help
determine whether PPly mediates the association of spinophilin with mGluRla and
mGluR5a.
The regulation by spinophilin is determined on the basis of its phosphorylation
S

state (Baucum et al., 2010; Feng et al., 2000; Grossman et al., 2002; Grossman et al.,
2004; Hsieh-Wilson et al., 2003; Uematsu et al., 2005). For example, following PKA
phosphorylation of Ser-177, spinophilin relocates from the post synaptic density (PSD)
and becomes enriched in the cytosol (Hsieh-Wilson et al., 2003). Phosphorylation at
this site also decreases the ability of spinophilin to regulate the trafficking of the a2Aadrenergic receptor (Xu et al., 2008). Therefore, future experiments are required to
allow the assessment of whether spinophilin phosphorylation is required for spinophilin
binding and regulation of Group I mGluRs.
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4. 3 Role of Spinophilin in the Agonist Induced Internalization of mGIuRl

Spinophilin interacts with and regulates the internalization and signalling of the
012AR (Brady et al., 2003; Brady et al., 2005; Wang and Limbird, 2002; Wang, Q., et al.,
2004). More specifically, spinophilin retains the 012AR at the plasma membrane by
competing with GRK2 for binding to the third intracellular loop and prevents subsequent
p-arrestin-dependent and clathrin-mediated endocytosis of the receptor (Brady et al.,
2003; Wang and Limbird, 2002; Wang, Q., et al., 2004). Wang Q., et al. (2004) found
that spinophilin and p-arrestin dynamically regulate (X2AR phosphorylation,
internalization and signalling both in vitro and in vivo. Therefore, we tested whether
over-expression of spinophilin prevents the agonist-induced internalization of both
mGluRla and mGluR5a. We show that spinophilin antagonizes mGluRla endocytosis
without increasing G protein-mediated signalling. This suggests the possibility that
spinophilin might not compete for GRK2 binding to Group I mGluRs. However, this
possibility remains to be determined.
Group I mGluRs undergo internalization by a number of distinct mechanisms
depending on how internalization is initiated and the splice variant studied. Both
mGluR la and mGluR5a are suggested to undergo internalization via both a classical
model of internalization (a GRK-phosphorylation- and P-arrestin-dependent pathway),
as well as agonist-stimulated and constitutive pathways that are GRK2-phosphorylationand p-arrestin-independent (Dhami and Ferguson, 2006). However, spinophilin does not
attenuate mGluR la G protein signalling, it is also possible that by competing with
GRK2 to bind Group I mGluRs, it prevents the phosphorylation-independent
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mGluRla/5a internalization (Ribeiro et al., 2009). Future experimentation will be
essential for understanding the relative roles of GRK2 and spinophilin in the regulation
of the internalization of Group I mGluRs.
Spinophilin tethers the a-adrenergic receptor to the cell surface via its coiledcoil interactions and by preventing GRK2 interaction (Wang et al., 2005). As a
consequence, spinophilin has been described as a scaffolding protein that provides a
mechanism for receptors to interact with protein partners and the cytoskeleton (Brady et
al., 2003; Sarrouilhe et al., 2006). Consistent with this observation, we find that
spinophilin over-expression antagonizes the internalization of mGluRla. To date, a
variety of protein interactions with the mGluRla/5a C-tails have been reported to
regulate the trafficking and signalling of these receptors (Croci et al., 2003;
Kammermeier and Ikeda, 2001; Kammermeier, 2008; Kitano et al., 2002; Ronesi and
Huber, 2008). For example, Homer proteins interact with the C-tail of Group I mGluRs
(Kammermeier, 2008; Ronesi and Huber, 2008). Similar to spinophilin, Homer proteins
\

function as scaffolds promoting the formation of mGluRl/5 regulated protein complexes
at the post synaptic density (Magalhaes et al., 2011). Whether spinophilin contributes in
a similar way to the scaffolding of synaptic protein complexes with mGluRla/mGluR5a
at post synaptic densities remains to be determined.
4 .4 . Role of Spinophilin in mGluRla-mediated Inositol Phosphate Formation

Group I mGluRs activate the heterotrimeric GOq/n protein which leads to the: 1)
activation of phospholipase Cß, 2) formation of IP3 and DAG, 3) release of calcium
from intracellular stores and 4) activation of effector enzymes such as protein kinase C
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and ERK1/2 (Dhami and Ferguson, 2006; Kawabata et al., 1998; Wang, J., et al., 2007).
We found that spinophilin over-expression attenuated mGluRla-mediated ERK1/2
phosphorylation without affecting inositol phosphate formation in response mGluRla
stimulation. This indicates that the interaction between spinophilin and mGluR la results
in the antagonism of the activation of ERK1/2 signalling without affecting Gaq/nmediated inositol phosphate formation. This suggests that the formation of intracellular
scaffolding protein complexes with mGluR la may bias intracellular signalling pathways
activated by mGluR 1a. This is akin to the observed effect of biased GPCR ligands that
influence distinct GPCR conformations to activate selective set of intracellular
signalling pathways (Gesty-Palmer and Luttrell, 2011; Niswender and Conn, 2010).
In addition to retaining the dieAR to the plasma membrane by preventing parrestin-mediated a )BAR endocytosis, spinophilin also recruits RGS2 to the signalling
complex to prevent the prolonged activation of signalling cascades induced by the Gaq/n
protein (Wang et al., 2005). Additionally, Wang, X., et a l (2005) found that spinophilin
is less effective in regulating calcium currents in RGS2 deficient cells and RGS2 is less
effective in inhibiting calcium current in spinophilin deficient cells. To determine
whether spinophilin regulates mGluR la signalling by recruiting RGS2, future
experiments examining the over-expression and knockdown of both RGS2 and
spinophilin on mGluR la signalling is required.
4.5 Role of Spinophilin in mGluRl-Mediated ERK1/2 Activation

It is well established that MAPK activation by Group I mGluRs involves
different protein partners and a selection of distinct signalling pathways (Emery et al.,
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2010; Iacovelli et al., 2003; Wang, J., et al., 2007). Voulalas et al. (2005) have reported
that PPly regulates MAPK activation induced by mGluRl/5 stimulation. Specifically,
they have shown that the blockade of PPly by phosphatase inhibitors increases
mGluRl/5-mediated ERK1/2 phosphorylation. Consequently, the potential association
of spinophilin in a complex with PP1 and Group I mGluRs may contribute to the direct
inactivation of ERK1/2 phosphorylation. To confirm this hypothesis, mGluRlastimulated ERK1/2 phosphorylation needs to be assessed following the over-expression
and knockdown of both PPly and spinophilin proteins.
4.6 Summary

In summary, we have shown here that spinophilin associates with mGluRla and
mGluR5a, potentially via its association with PPly or mGluRla/5a the PDZ binding
motifs. Moreover, we demonstrate that spinophilin antagonizes both mGluRla
endocytosis and ERK1/2 phosphorylation. This occurs in the absence of attenuated
mGluRla-stimulated inositol phosphate formation. These observations indicate that the
interaction of proteins with the intracellular face of Group I mGluRs can influence the
agonist-stimulated coupling of receptors to distinct intracellular signalling pathways.
This opens the window to specifically target protein interfaces required for selective
activation of unique signalling pathways that may be inhibited to treat neurodegenerative
diseases.
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